Literature DB >> 29171655

Oral sampling methods are associated with differences in immune marker concentrations.

Carole Fakhry1, Fares Qeadan2, Robert H Gilman3, Pablo Yori3, Margaret Kosek3, Nicole Patterson4, David W Eisele5, Christine G Gourin5, Chandala Chitguppi6, Morgan Marks7, Patti Gravitt8.   

Abstract

OBJECTIVE: To determine whether the concentration and distribution of immune markers in paired oral samples were similar. STUDY TYPE: Clinical research. STUDY
DESIGN: Cross-sectional study.
METHODS: Paired saliva and oral secretions (OS) samples were collected. The concentration of immune markers was estimated using Luminex multiplex assay (Thermo Fisher Scientific, Waltham, MA). For each sample, the concentration of respective immune markers was normalized to total protein present and log-transformed. Median concentrations of immune markers were compared between both types of samples. Intermarker correlation in each sampling method and across sampling methods was evaluated.
RESULTS: There were 90 study participants. Concentrations of immune markers in saliva samples were significantly different from concentrations in OS samples. Oral secretions samples showed higher concentrations of immunoregulatory markers, whereas the saliva samples contained proinflammatory markers in higher concentration.
CONCLUSION: The immune marker profile in saliva samples is distinct from the immune marker profile in paired OS samples. LEVEL OF EVIDENCE: 2b. Laryngoscope, 128:E214-E221, 2018.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Oral samples; head and neck cancer; immune markers

Mesh:

Substances:

Year:  2017        PMID: 29171655      PMCID: PMC5967988          DOI: 10.1002/lary.27002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  35 in total

1.  Comparison of the immune microenvironment of the oral cavity and cervix in healthy women.

Authors:  Carole Fakhry; Morgan A Marks; Robert H Gilman; Lilia Cabrerra; Pablo Yori; Margaret Kosek; Patti E Gravitt
Journal:  Cytokine       Date:  2013-09-07       Impact factor: 3.861

2.  Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women.

Authors:  Morgan A Marks; Raphael P Viscidi; Kathryn Chang; Michelle Silver; Anne Burke; Roslyn Howard; Patti E Gravitt
Journal:  Cytokine       Date:  2011-10-19       Impact factor: 3.861

3.  Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.

Authors:  Salman Aziz; Syed Shoaib Ahmed; Asad Ali; Faiza Akhter Khan; Gulraiz Zulfiqar; Javed Iqbal; Ayyaz Ali Khan; Muhammad Shoaib
Journal:  Cancer Invest       Date:  2015-06-05       Impact factor: 2.176

4.  Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.

Authors:  Tanguy Y Seiwert; Barbara Burtness; Ranee Mehra; Jared Weiss; Raanan Berger; Joseph Paul Eder; Karl Heath; Terrill McClanahan; Jared Lunceford; Christine Gause; Jonathan D Cheng; Laura Q Chow
Journal:  Lancet Oncol       Date:  2016-05-27       Impact factor: 41.316

5.  Adherent interactions which may affect microbial ecology in the mouth.

Authors:  R J Gibbons
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

6.  Effect of the menstrual cycle on inflammatory cytokines in the periodontium.

Authors:  M Khosravisamani; G Maliji; S Seyfi; A Azadmehr; B Abd Nikfarjam; S Madadi; S Jafari
Journal:  J Periodontal Res       Date:  2014-02-12       Impact factor: 4.419

7.  A novel cytokine profile associated with cancer metastasis to mediastinal and hilar lymph nodes identified using fine needle aspiration biopsy - A pilot study.

Authors:  Ali I Saeed; Fares Qeadan; Akshay Sood; Dorothy J VanderJagt; Shiraz I Mishra; Deirdre A Hill; Tobias Peikert; Mohan L Sopori
Journal:  Cytokine       Date:  2016-09-03       Impact factor: 3.861

8.  Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.

Authors:  Pi-Yueh Chang; Yung-Bin Kuo; Tsu-Lan Wu; Chun-Ta Liao; Yu-Chen Sun; Tzu-Chen Yen; Err-Cheng Chan
Journal:  Clin Chem Lab Med       Date:  2013-06       Impact factor: 3.694

9.  Oral fluids as an alternative to serum for measurement of markers of immune activation.

Authors:  P Nishanian; N Aziz; J Chung; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

10.  Resistance/response molecular signature for oral tongue squamous cell carcinoma.

Authors:  Amritha Suresh; Muhil Vannan; Dhanya Kumaran; Zeynep H Gümüs; Priya Sivadas; Elango Erode Murugaian; Vikram Kekatpure; Subramanian Iyer; Kumarasamy Thangaraj; Moni Abraham Kuriakose
Journal:  Dis Markers       Date:  2012       Impact factor: 3.434

View more
  2 in total

1.  Mouthwash-Based Highly Sensitive Pyro-Genotyping for Nine Sexually Transmitted Human Papilloma Virus Genotypes.

Authors:  Yoshiyuki Watanabe; Yukiko Seto; Ritsuko Oikawa; Takara Nakazawa; Hanae Furuya; Hidehito Matsui; Sachiko Hosono; Mika Noike; Akiko Inoue; Hiroyuki Yamamoto; Fumio Itoh; Kota Wada
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

2.  The MK2 pathway is linked to G-CSF, cytokine production and metastasis in gastric cancer: a novel intercorrelation analysis approach.

Authors:  Fares Qeadan; Pranshu Bansal; Joshua A Hanson; Ellen J Beswick
Journal:  J Transl Med       Date:  2020-03-26       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.